OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escape
Jiawen Cui, Yao Li, Yang Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116203-116203
Open Access | Times Cited: 36
Jiawen Cui, Yao Li, Yang Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116203-116203
Open Access | Times Cited: 36
Showing 1-25 of 36 citing articles:
Recent Treatment Strategies and Molecular Pathways in Resistance Mechanisms of Antiangiogenic Therapies in Glioblastoma
Md. Ataur Rahman, Meser M. Ali
Cancers (2024) Vol. 16, Iss. 17, pp. 2975-2975
Open Access | Times Cited: 9
Md. Ataur Rahman, Meser M. Ali
Cancers (2024) Vol. 16, Iss. 17, pp. 2975-2975
Open Access | Times Cited: 9
Insights into tumor-derived exosome inhibition in cancer therapy
Ziwei Tang, Cheng Chen, Chen Zhou, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117278-117278
Closed Access | Times Cited: 1
Ziwei Tang, Cheng Chen, Chen Zhou, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117278-117278
Closed Access | Times Cited: 1
Targeting PI3K signaling in Lung Cancer: advances, challenges and therapeutic opportunities
Bitian Zhang, Ping‐Chung Leung, William C. Cho, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Bitian Zhang, Ping‐Chung Leung, William C. Cho, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
PTMs of PD-1/PD-L1 and PROTACs application for improving cancer immunotherapy
Xiaohui Ren, Lijuan Wang, Likun Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Xiaohui Ren, Lijuan Wang, Likun Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Predictive Biomarkers and Resistance Mechanisms of Checkpoint Inhibitors in Malignant Solid Tumors
Luciana Alexandra Pavelescu, Robert Mihai Enache, Oana Alexandra Roşu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9659-9659
Open Access | Times Cited: 5
Luciana Alexandra Pavelescu, Robert Mihai Enache, Oana Alexandra Roşu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9659-9659
Open Access | Times Cited: 5
Peptides as Versatile Regulators in Cancer Immunotherapy: Recent Advances, Challenges, and Future Prospects
Yu Lei, Jiacheng Liu, Yaowei Bai, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 46-46
Open Access
Yu Lei, Jiacheng Liu, Yaowei Bai, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 46-46
Open Access
Ultrasound-Guided Histotripsy Triggers the Release of Tumor-Associated Antigens from Breast Cancers
Shengzhuang Tang, Reliza McGinnis, Zhengyi Cao, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 183-183
Open Access
Shengzhuang Tang, Reliza McGinnis, Zhengyi Cao, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 183-183
Open Access
Advancing brain immunotherapy through functional nanomaterials
Bhanu Nirosha Yalamandala, Thi My Hue Huynh, Hui-Wen Lien, et al.
Drug Delivery and Translational Research (2025)
Open Access
Bhanu Nirosha Yalamandala, Thi My Hue Huynh, Hui-Wen Lien, et al.
Drug Delivery and Translational Research (2025)
Open Access
Non‐Genetic Biomarkers in Merkel Cell Carcinoma: Prognostic Implications and Predictive Utility for Response to Anti‐PD ‐(L)1 Immune Checkpoint Inhibitors
David L. Drum, Anika G. Jallorina, Leo Q. Wan, et al.
Experimental Dermatology (2025) Vol. 34, Iss. 1
Closed Access
David L. Drum, Anika G. Jallorina, Leo Q. Wan, et al.
Experimental Dermatology (2025) Vol. 34, Iss. 1
Closed Access
Signatures of H3K4me3 modification predict cancer immunotherapy response and identify a new immune checkpoint-SLAMF9
Tao Fan, Xiao Chu, Ziqin Deng, et al.
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access
Tao Fan, Xiao Chu, Ziqin Deng, et al.
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access
Therapeutic Applications of Plant Virus Nanoparticles in Cancer Treatment and Nanomedicine
Muhammad Majid, Muhammad Safdar Hussain, Hamza Khaliq, et al.
Indus journal of bioscience research. (2025) Vol. 3, Iss. 1, pp. 429-437
Closed Access
Muhammad Majid, Muhammad Safdar Hussain, Hamza Khaliq, et al.
Indus journal of bioscience research. (2025) Vol. 3, Iss. 1, pp. 429-437
Closed Access
Immune Cell Interactions and Immune Checkpoints in the Tumor Microenvironment of Gastric Cancer
Andreea-Raluca Cozac-Szőke, Dan Alexandru Cozac, Anca Negovan, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1156-1156
Open Access
Andreea-Raluca Cozac-Szőke, Dan Alexandru Cozac, Anca Negovan, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1156-1156
Open Access
The Potential Role of PD-1/PD-L1 Small Molecule Inhibitors in Colorectal Cancer with Different Mechanisms of Action
Suhaibee Kuno, Nattaporn Pakpian, Chatchai Muanprasat
European Journal of Pharmacology (2025), pp. 177351-177351
Closed Access
Suhaibee Kuno, Nattaporn Pakpian, Chatchai Muanprasat
European Journal of Pharmacology (2025), pp. 177351-177351
Closed Access
Extracellular Vesicle-Based Strategies for Tumor Immunotherapy
Luksika Jiramonai, Xing-Jie Liang, Mengliang Zhu
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 257-257
Open Access
Luksika Jiramonai, Xing-Jie Liang, Mengliang Zhu
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 257-257
Open Access
Mycobacterium tuberculosis infection may increase the degrees of malignancy in lung adenocarcinoma
Shanshan Li, Mengru Feng, Fenghua Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Shanshan Li, Mengru Feng, Fenghua Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Exploring Immune Checkpoint Inhibitors: Focus on PD-1/PD-L1 Axis and Beyond
Durre Aden, Samreen Zaheer, Niti Sureka, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155864-155864
Closed Access
Durre Aden, Samreen Zaheer, Niti Sureka, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155864-155864
Closed Access
Exploring radiation resistance-related genes in pancreatic cancer and their impact on patient prognosis and treatment
Dong Dai, Sen Wang, J. Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Dong Dai, Sen Wang, J. Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Evaluating the Tumor Burden, Histological Changes, and Immune Landscape of Breast Cancer Post-neoadjuvant Chemotherapy: Insights From 50 Cases
Arasi Rajesh, Dharma Saranya Gurusamy, Rajalakshmi Manikkam
Cureus (2025)
Open Access
Arasi Rajesh, Dharma Saranya Gurusamy, Rajalakshmi Manikkam
Cureus (2025)
Open Access
Current advancement of immune function paradox of tumour-infiltrating cells and their immunotherapeutic targets: a mini-review
VEENA V. TOM, A. De la Fuente Hernández José, Sumit Mallick, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
VEENA V. TOM, A. De la Fuente Hernández José, Sumit Mallick, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
The Dual Role of Chaperone-mediated Autophagy in the Response and Resistance to Cancer Immunotherapy
Mohammadreza Saberiyan, Sarah Gholami, Mahsa Ejlalidiz, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 210, pp. 104700-104700
Open Access
Mohammadreza Saberiyan, Sarah Gholami, Mahsa Ejlalidiz, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 210, pp. 104700-104700
Open Access
pH-responsive nanocomplex for active transport of aPD-1 and PTX to enhance cancer chemoimmunotherapy
Yating Qin, Yan Lin, Chao Tian, et al.
Nano Today (2025) Vol. 62, pp. 102710-102710
Closed Access
Yating Qin, Yan Lin, Chao Tian, et al.
Nano Today (2025) Vol. 62, pp. 102710-102710
Closed Access
Monoclonal antibody immune therapy response instrument for stratification and cost-effective personalized approaches in 3PM-guided pan cancer management
Salem Baldi, Mohammed Alnaggar, Maged AL-Mogahed, et al.
The EPMA Journal (2025)
Closed Access
Salem Baldi, Mohammed Alnaggar, Maged AL-Mogahed, et al.
The EPMA Journal (2025)
Closed Access
Innovative dual-gene delivery platform using miR-124 and PD-1 via umbilical cord mesenchymal stem cells and exosome for glioblastoma therapy
Po‐Fu Yueh, I‐Tsang Chiang, Yueh‐Shan Weng, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Po‐Fu Yueh, I‐Tsang Chiang, Yueh‐Shan Weng, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword
Sina Kamrani, Reza Naseramini, Pouria Khani, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Sina Kamrani, Reza Naseramini, Pouria Khani, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Anti-tumor effectiveness of a novel bispecific antibody that blocks both PD-L1 and LAG-3
Chenxing Zhang, Jiaxin Liu, Mingzhe Sun, et al.
Molecular Immunology (2025) Vol. 182, pp. 30-40
Open Access
Chenxing Zhang, Jiaxin Liu, Mingzhe Sun, et al.
Molecular Immunology (2025) Vol. 182, pp. 30-40
Open Access
